PD-L1/CD137 (Bicycle Therapeutics)

N/A

Report date: 2025/01/26 16:30:05

Base Information

Drug NamePD-L1/CD137 (Bicycle Therapeutics)
Drug Alias NameDual 4-1BB costimulator/anti-PD-L1 (Bicycle Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProgrammed death-ligand 1 modulatorsTumor necrosis factor receptor superfamily member 9 stimulants
TargetsProgrammed death-ligand 1Tumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBicycle Tx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBicycle Tx Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A